PTEN Gene and Its Markers in Prostate Cancer
Author Information
Author(s): Hamilton J A, Stewart L M D, Ajayi L, Gray I C, Gray N E, Roberts K G, Watson G J, Kaisary A V, Snary D
Primary Institution: Applied Development Laboratory, Imperial Cancer Research Fund
Hypothesis
The study investigates the expression profile of the PTEN gene and its associated polymorphic markers in relation to prostate cancer.
Conclusion
The study found that certain polymorphisms within the PTEN gene may indicate a predisposition to prostate cancer.
Supporting Evidence
- PTEN is located within the chromosomal region 10q23.3.
- Multiple mRNA species arise from the PTEN gene due to alternative polyadenylation.
- Two known and one novel microsatellite markers were identified within the PTEN gene.
- Four common polymorphisms within the PTEN gene appear to be linked.
- DNA from 200 individuals confirmed the link between polymorphisms and prostate cancer.
Takeaway
Scientists looked at a gene called PTEN to see if changes in it could make people more likely to get prostate cancer, and they found some clues that suggest it might.
Methodology
The study used Northern blots and RACE studies to analyze PTEN expression and identify polymorphisms in DNA from individuals.
Limitations
The study's sample size was small, and only a few cases of advanced prostate cancer were examined.
Participant Demographics
The study included 200 individuals, comprising normal individuals, those with benign prostatic hyperplasia (BPH), and prostate cancer patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website